Table 4.
Variable | Estimate | Standard Error | 95% Confidence Intervals | t Value | P value | |
---|---|---|---|---|---|---|
Intercept | 43.88 | 2.27 | 39.44 | 48.33 | 19.31 | <0.0001 |
Week 1 | −4.85 | 1.44 | −7.65 | −2.05 | −3.38 | <0.001 |
Week 2 | −7.70 | 1.44 | −10.50 | −4.90 | −5.37 | <0.0001 |
Week 3 | −8.08 | 1.44 | −10.88 | −5.29 | −5.63 | <0.0001 |
active tDCS | −1.88 | 3.21 | −8.17 | 4.40 | −0.59 | 0.56 |
Week 1: active tDCS | 0.12 | 2.03 | −3.84 | 4.07 | 0.06 | 0.95 |
Week 2: active tDCS | −3.88 | 2.03 | −7.84 | 0.07 | −1.91 | 0.06 |
Week 3: active tDCS | −2.87 | 2.02 | −6.82 | 1.09 | −1.41 | 0.16 |
Note. The baseline is used as the reference level for the time factor, and the sham tDCS group is used as the reference level for the intervention factor. “Week 1: active tDCS” denotes the interaction between the time factor and the treatment.